Evaluation of effects of autologous fat grafting on aesthetic outcomes in breast reconstruction following mastectomy: Effects of reconstruction type and prior radiotherapy exposure.
Omar S., Darwish AMA., Sosnowski K., El-Henawy A., Othman A., Malata C.
Retrospective Study, published in JPRAS Open (2026) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Retrospective Study
- Journal
- JPRAS Open (2026)
- Country
- Netherlands
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 42281906
- PMCID
- PMC13251801
- DOI
- 10.1016/j.jpra.2026.05.027
Abstract (original English)
Autologous fat grafting improves breast reconstruction aesthetics, yet impact relative to natural post-reconstructive changes remains poorly characterized. Retrospective analysis of 92 reconstructions (42 fat-grafted, 50 non-grafted) using BCCT.core and Harvard Scale assessments at 6-12 months. Non-grafted reconstructions demonstrated significant deterioration (46%; BCCT.core p = 0.027, Harvard p < 0.001) uniformly across modalities. Conventional 3-week radiotherapy produced greater deterioration than 5-day regimens ( p = 0.036, p = 0.024). Fat grafting reversed this trajectory, achieving 88.1% versus 4% complete complaint resolution (Mann-Whitney p < 0.001; effect sizes 0.41-0.84) across all reconstruction types and radiotherapy exposures. Irradiated reconstructions demonstrated greatest gains. One to two sessions typically sufficed. Post-reconstructive deterioration should be anticipated. Fat grafting functions as regenerative intervention modifying biological maturation. Findings support proactive staged incorporation into algorithms, particularly for irradiated patients.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • Without an adequate control group, treatment effects cannot be separated from other factors.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.